Citation: | WU Yun, CHEN Jiawei, WANG Tong, LI Jin, ZHANG Ge, KANG Wei, ZHANG Jingjia, SUN Hongli, XU Yingchun, LIU Yali. In Vitro Activity of Sixteen Drugs Against Staphylococcus Aureus, Enterococcus Faecalis and Enterococcus Faecium: A Multicentre Cross-sectional Study in China[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 999-1004. DOI: 10.12290/xhyxzz.2023-0070 |
[1] |
Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens[J]. Expert Rev Anti Infect Ther, 2013, 11: 297-308. DOI: 10.1586/eri.13.12
|
[2] |
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. 33rd ed. CLSI document M100. Wayne, PA: CLSI, 2023.
|
[3] |
European Committee on Antimicrobial Susceptibility Testing. EUCAST clinical breakpoint table [EB/OL]. [2023-02-10]. https://www.eucast.org/clinical_breakpoints/.
|
[4] |
Arias CA, Murray BE. Emergence and management of drug-resistant enterococcal infections[J]. Expert Rev Anti Infect Ther, 2008, 6: 637-55. DOI: 10.1586/14787210.6.5.637
|
[5] |
CHINET中国细菌耐药监测网.CHINET中国细菌耐药检测结果(2022年1—12月)[EB/OL ].(2022-09)[2023-07-03]. https://max.book118.com/html/2022/0913/6213051034004235.shtm.
|
[6] |
Ding L, Yang Y, Zheng C, et al. Activities of Eravacycline, Tedizolid, Norvancomycin, Nemonoxacin, Ceftaroline, and Comparators against 1, 871 Staphylococcus and 1, 068 Enterococcus Species Isolates from China: Updated Report of the CHINET Study 2019 [J]. Microbiol Spectr, 2022, 10: e0171522. DOI: 10.1128/spectrum.01715-22
|
[7] |
Shariati A, Dadashi M, Chegini Z, et al. The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopri-stin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: a systematic review and meta-analysis. Antimicrob Resist Infect Control [J]. Antimicrob Resist Infect Control, 2020, 9: 56.
|
[8] |
Schöfer H, Simonsen L. Fusidic acid in dermatology: an updated review [J]. Eur J Dermatol, 2010, 20: 6-15. DOI: 10.1684/ejd.2010.0833
|
[9] |
Goudarzi M, Seyedjavadi S, Bagheri P, et al. Prevalence and genetic characteristics of fusidic acid resistant Staphylococcus aureus clinical isolates: Emergence of t030 strains carrying fusB in Tehran, Iran [J]. Acta Microbiol Immunol Hung, 2023, 70: 126-133. DOI: 10.1556/030.2023.01997
|
[10] |
Zhanel GG, Adam HJ, Baxter M, et al. In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18) [J]. J Antimicrob Chemother, 2021, 76: 1808-1814. DOI: 10.1093/jac/dkab098
|
[11] |
Chen S, Rao L, Lin C. The Dissemination of Fusidic Acid Resistance Among Staphylococcus epidermidis Clinical Isolates in Wenzhou, China [J]. Infect Drug Resist, 2022, 15: 2537-2544. DOI: 10.2147/IDR.S365071
|
[12] |
Liu X, Deng S, Huang J, et al. Dissemination of macrolides, fusidic acid and mupirocin resistance among Staphylococcus aureus clinical isolates [J]. Oncotarget, 2017, 8: 58086-58097.
|
[13] |
胡付品, 郭燕, 朱德妹, 等. 2018年CHINET中国细菌耐药性监测[J]. 中国感染与化疗杂志, 2020, 20: 1-10. https://www.cnki.com.cn/Article/CJFDTOTAL-KGHL202001001.htm
|
[14] |
胡付品, 郭燕, 朱德妹, 等. 2020年CHINET中国细菌耐药监测[J]. 中国感染与化疗杂志, 2021, 21: 377-387. https://www.cnki.com.cn/Article/CJFDTOTAL-KGHL202205001.htm
|
[15] |
郑永贵, 胡付品, 朱德妹, 等. 2019年CHINET细菌耐药监测网二级医院监测结果[J]. 中国感染与化疗杂志, 2020, 20: 585-593. https://www.cnki.com.cn/Article/CJFDTOTAL-KGHL202006001.htm
|
[1] | LIU Xiaoyu, YAN Chaowu, WU Dong, DANZENG Pingcuo, XU Zhonghui. Preliminary Screening of Health Status Among Preschool Children in Extremely High Altitude Areas of Tibet, China[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-1056 |
[2] | DUAN Hanyu, ZHU Qianmei, Cirendeji, LI Yi, MIAO Xuhan, ZHANG Yuelun, LIU Zijia, Labaciren, SHEN Le, HUANG Yuguang. Risk Factors of Hypoxemia During Non-cardiothoracic Surgery for Populations at High Altitude in Tibet: A Prospective Cohort Study[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 646-651. DOI: 10.12290/xhyxzz.2022-0610 |
[3] | WU Zengyu, ZHANG Yuechuan, PENG Yue, WU Nan, QIU Guixing, ZHUANG Qianyu, ZHANG Jianguo. Genetic Polymorphisms of SPRY4 are Associated with Adolescent Idiopathic Scoliosis in Chinese Han Population: A Single Center Retrospective Study[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 553-558. DOI: 10.12290/xhyxzz.2022-0575 |
[4] | GAO Zhongshan, REN Ming, MA Yulan, ZHU Lulu. Polymorphism of Gut Microbiota in High Altitude Tibetan Patients with Coronary Artery Heart Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 332-340. DOI: 10.12290/xhyxzz.2021-0652 |
[5] | WANG Pei, MA Liangkun, LIU Juntao. Difference in Gut Microbiota between the First and the Second Trimester of Pregnancy and the Association of Gut Microbiota with Gestational Diabetes Mellitus: A Prospective Cohort Study[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 721-728. DOI: 10.12290/xhyxzz.20200122 |
[6] | Bei-di CHEN, Li-dan ZHAO, Xuan ZHANG. Gut Microbiota and Systemic Lupus Erythematosus[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(3): 258-263. DOI: 10.3969/j.issn.1674-9081.20200056 |
[7] | Ri-liga WU, Rong MU. Intestinal Microbiota in Systemic Sclerosis[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 263-267. DOI: 10.3969/j.issn.1674-9081.2019.03.013 |
[8] | Li-wei WANG, Zhi-min DUAN, Jian-bo TONG, Rong ZENG, Hao-xiang XU, Min LI. Diversity Analysis of Intestinal Microbiota in Psoriasis Patients: A Single-center Prospective Study[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 223-230. DOI: 10.3969/j.issn.1674-9081.2019.03.007 |
[9] | Ying-he LI, Xiang-chen MENG, Peng-guang YAN, Hong YANG, Ji LI, Jia-ming QIAN, Jing-nan LI. Relevance between Glucocorticoid Treatment and the Intestinal Microbiota of Patients with Moderately Severe Ulcerative Colitis: A Single-center Retrospective Study[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 216-222. DOI: 10.3969/j.issn.1674-9081.2019.03.006 |
[10] | Yu-hao JIAO, Feng-chun ZHANG. New Insights into Research on the Role of Gut Microbiota in Human Immune System[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(3): 193-196. DOI: 10.3969/j.issn.1674-9081.2019.03.001 |